Skip to main content
Equibles
MORN logo

MORN · Morningstar, Inc.

Track MORN — free

Use MORN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$218.99 +1.34 (+0.62%) At close · Aug 31
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$8.16B
Shares
37.51M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$217.65 Open$218.49 Day$216.24–220.44 52W close$141.84–262.42 Avg vol 30d370K Short int1.5M · 4.1% float · 4.9d Short vol52% Last earningsJul 29, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 29

Up next

Next earnings call
Mar 14, 2029 Est · unconfirmed · in 132 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Jul 29, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Bearish Fundamentals Strong Quant / Vol High
Market backdrop VIX 14.4 · calm Equity put/call 0.62
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +16%
above
Price vs 50-day avg +18%
above
RSI (14) 68
neutral
MACD trend Negative
52-week position 63%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return +13%
trailing
6-month return +14%
trailing
YTD return 0%
this year
Relative strength +1%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $184 › 200d $188 — 200d above 50d
Institutional flow Distributing
-6% holders QoQ · +69 funds added
Insider flow Distributing
Net -$199.0K over 90 days · 100% sells
Short interest Rising
4.09% of float · ▲ +5.2% MoM · 4.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
419 holders — mid 3-yr range
Squeeze score 71
high risk · 0–100
Fundamentals
Strong
Revenue growth +7%
Y/Y
EPS growth +3%
Y/Y
Free cash flow $442.6M
Valuation P/E 20.7
below peers
Buyback $300.0M
remaining
Balance sheet $598.1M
net debt
Quant / Vol
risk profile
High
Volatility 40%
annualized · 1-yr
Max drawdown −46%
past year
ATR 3.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+16% Bullish
Price vs 50-day avg
+18% Bullish
RSI (14)
68 Neutral
MACD trend
Negative Bearish
52-week position
63% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross) No cross
50d $184 › 200d $188 — 200d above 50d
Institutional flow Distributing
-6% holders QoQ · +69 funds added
Insider flow Distributing
Net -$199.0K over 90 days · 100% sells
Short interest Rising
4.09% of float · ▲ +5.2% MoM · 4.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
419 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $142 Now $218 · 63% Range high $262
vs 200-day avg +16% vs 50-day avg +18%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
GAAP → non-GAAP reconciliation
GAAP Operating Income (Quarterly) $160.6
+$15.3 Excluding (1) intangible amortization expense, (2) M&A-related expenses, and (3) other non-recurring items
= Adjusted Operating Income (Quarterly) $175.9
Adjusted Operating Income (TTM) non-GAAP $658.6M Q2 26 —
GAAP → non-GAAP reconciliation
GAAP Operating Income (TTM) $603.9
+$54.7 Excluding (1) intangible amortization expense, (2) M&A-related expenses, and (3) other non-recurring items (TTM)
= Adjusted Operating Income (TTM) $658.6
GAAP → non-GAAP reconciliation
GAAP Operating Margin 24.2%
+2.3% Excluding (1) intangible amortization expense, (2) M&A-related expenses, and (3) other non-recurring items
= Adjusted Operating Margin 26.5%
Combined Morningstar Model Portfolio and International Wealth Platform AUMA 55.3M Q2 2026 —
Float reduction since December 2025 5.6% since December 2025 —
GAAP → non-GAAP reconciliation
GAAP Cash provided by operating activities $155.7M
-$33.2M Capital expenditures
= Free cash flow $122.5M
Free cash flow (TTM) $497.5M Q2 26 —
GAAP → non-GAAP reconciliation
GAAP Cash provided by operating activities (TTM) $646.9
-$149.4 Capital expenditures (TTM)
= Free cash flow (TTM) $497.5
Free cash flow conversion (TTM) non-GAAP 75.5% Q2 2026 TTM —
Headcount 10,825 As of June 30, 2026 —
Organic revenue growth excluding sunsetting of certain products non-GAAP 8.2% Q2 2026 —
Share repurchases $100M Q2 2026 —
Year-to-date share repurchases $400M Q2 2026 year-to-date —
Adjusted Diluted Net Income Per Share non-GAAP $3.18 three months ended March 31, 2026 —
GAAP → non-GAAP reconciliation
GAAP Consolidated diluted net income per share $2.73
+$0.36 Intangible amortization expense
+$0.09 M&A-related expenses
-$0.02 Other non-recurring items
+$0.02 Non-operating (gains) losses
= Adjusted diluted net income per share $3.18
Adjusted Operating Expense non-GAAP $466.2M Q1 26 —
GAAP → non-GAAP reconciliation
GAAP Operating Expense $489.8M
-$23.6M Intangible amortization expense, M&A-related expenses, and other non-recurring items
= Adjusted Operating Expense $466.2M
GAAP → non-GAAP reconciliation
GAAP Consolidated operating income 155.9M
+19M Intangible amortization expense
+4.6M M&A-related expenses
-0.9M Other non-recurring items
= Adjusted operating income 178.6M
Adjusted Operating Income (Loss) - Morningstar Credit non-GAAP $41.2M Q1 26 —
Adjusted Operating Income (Loss) - Morningstar Direct Platform non-GAAP $91M Q1 26 —
Adjusted Operating Income (Loss) - Morningstar Retirement non-GAAP $19.8M Q1 26 —
Adjusted Operating Income (Loss) - PitchBook non-GAAP $51.6M Q1 26 —
Adjusted Operating Margin (Morningstar Retirement) non-GAAP 51% Q1 2026 —
Adjusted Operating Margin (PitchBook) non-GAAP 29.9% Q1 2026 —
Asset value linked to Morningstar Indexes $3.17T As of March 31, 2026 —
Organic revenue non-GAAP $617.8M three months ended March 31, 2026 —
GAAP → non-GAAP reconciliation
GAAP Consolidated revenue 644.8M
-10.5M Acquisitions
-3M Divestitures
-13.5M Effect of foreign currency translations
= Organic revenue 617.8M
Adjusted diluted net income per share growth non-GAAP 25% Full-Year 2025 —
Asset-Based Organic Revenue Growth non-GAAP 9.4% Q4 25 —
AUMA (approximate) 305.2B As of December 31, 2025 —
Consolidated Adjusted Operating Margin non-GAAP 23.9% Q4 25 —
Free cash flow growth 43% Q4 2025 —
License-Based Organic Revenue Growth non-GAAP 4.1% Q4 25 —
Morningstar Credit Canada Organic Revenue Growth non-GAAP 18.9% Q4 25 —
Morningstar Credit EMEA Organic Revenue Growth non-GAAP 30.6% Q4 25 —
Morningstar Credit Revenue $354.4M FY2025 —
Morningstar Wealth Revenue $63.7M Q4 2025 —
PitchBook segment adjusted operating income non-GAAP $52.1M Q4 2025 —
Shares repurchased 3,276,578 Full-Year 2025 —
Shares repurchased value $787M Full-Year 2025 —
Total AUMA $378B As of December 31, 2025 —
Transaction-Based Organic Revenue Growth non-GAAP 25.6% Q4 25 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Financial Data & Stock Exchanges — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MORN
Morningstar, Inc.
this stock
$8.16B +0.2% +7.5% 20.7 4.1%
SPGI
S&P Global Inc.
 $138.57B — +7.1% 29.6 2.4%
CME
Cme Group Inc.
 $102.77B +4.7% +6.4% 24.2 1.4%
ICE
Intercontinental Exchange, Inc.
 $91.13B +0.2% -2.1% 22.9 1.4%
MCO
Moodys Corp /De/
 $89.19B +0.8% +16.6% 32.7 1.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
419
% held
64.8%
Net QoQ
+671.0K sh
Top holder
BAMCO INC /NY/
Held Float
View
Held by Funds
Fund positions
421
View
Short & Settlement
Short Interest Rising
Shares short
1.5M
Days to cover
4.9d
Change
+76.5K sh
View
Short Volume
Short vol %
52%
As of
Aug 31, 2026
Short Total
View
Fails to Deliver
FTD shares
395
Value
$79.1K
As of
Aug 5, 2026
View
Off-Exchange
Off-exchange %
48.3%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$199.0K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Congressional Trades Sell
Member
April McClain Delaney
Amount
$1.0K–$15.0K
Traded
May 6, 2026
View
Financials
Financials
Revenue (FY)
$2.4B
Net income (FY)
$183.0M
EPS diluted
$8.87
View
Buybacks
Authorized
$1.0B
Remaining
$300.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 25, 2026
This year
15
View
Proposed Sales
Value
$19.9M
Shares
100.0K
Filed
Aug 3, 2026
View
Earnings & Events
Earnings Calls
Last call
Jul 29, 2026
View
Investor Relations
Latest news
Given the recent index acquisitio…
Published
Aug 25, 2026
View

Performance

5D 20D 120D MTD YTD
MORN +0.8% +13.0% +13.9% +13.0% +0.2%
SPY +0.5% +3.0% +13.4% +3.0% +12.8%
vs SPY +0.3% +10.0% +0.5% +10.0% -12.7%

Capital returns

Latest dividend
$0.50 / share · ex Jul 10, 2026
Declared · upcoming
$0.50 / share · ex Oct 2, 2026
Raised 9.9%
Paid (TTM)
$1.955 / share · 4 payouts
Dividend yield (TTM, derived)
0.90%
Buyback program · as of Jun 30, 2026
Authorized
$1.00B
Spent (derived)
$700.00M
Remaining
$300.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1289419 CUSIP 617700109 13F (30d) 302 filings 293 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)